Additionally, retinoids can reduce the invasiveness of prostate cancer cells by regulating the activity of matrix metalloproteinases (MMPs) and affecting androgen receptor-related (AR) signaling pathways [32]. This evidence concerns the gene AR and prostate carcinoma.